Edition:
United States

Menlo Therapeutics Inc (MNLO.OQ)

MNLO.OQ on NASDAQ Stock Exchange Global Select Market

5.62USD
2:28pm EST
Change (% chg)

$-0.08 (-1.40%)
Prev Close
$5.70
Open
$5.74
Day's High
$5.92
Day's Low
$5.62
Volume
5,035
Avg. Vol
44,412
52-wk High
$38.68
52-wk Low
$5.23

Chart for

About

Menlo Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of serlopitant for the treatment of pruritus (itch) associated with dermatologic conditions, such as atopic dermatitis, psoriasis and prurigo nodularis. It is also evaluating the use of serlopitant for the... (more)

Overall

Beta: --
Market Cap(Mil.): $133.12
Shares Outstanding(Mil.): 23.23
Dividend: --
Yield (%): --

Financials

  MNLO.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -1.73 -- --
ROI: -33.53 0.60 13.80
ROE: -73.04 -2.18 15.29

Earnings vs. Estimates